Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 14/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5020443 | 0.94 | HSP90AA1 (0.35) | TGFBR1FFAR1HSP90AA1HKDC1CCR1 | |
| SCHEMBL5020348 | 0.94 | TGFBR1 (0.34) | TGFBR1FFAR1 | |
| SCHEMBL5020229 | 0.90 | TGFBR1 (0.34) | TGFBR1FFAR1CCR1CCR8 | |
| SCHEMBL5020366 | 0.88 | CCR1 (0.41) | HSP90AA1HKDC1CCR1CCR8DUSP3 | |
| SCHEMBL15465604 | 0.88 | GRM5 (0.34) | HSP90AA1HKDC1CCR1CCR8DUSP3 | |
| SCHEMBL5020365 | 0.88 | CCR1 (0.35) | HSP90AA1HKDC1CCR1CCR8DUSP3 | |
| SCHEMBL15465601 | 0.88 | GRM5 (0.34) | HSP90AA1HKDC1CCR1CCR8DUSP3 | |
| SCHEMBL5020221 | 0.88 | GRM5 (0.34) | HSP90AA1HKDC1CCR1CCR8DUSP3 | |
| SCHEMBL5020228 | 0.88 | FFAR1 (0.41) | TGFBR1FFAR1 | |
| SCHEMBL5020344 | 0.87 | FFAR1 (0.34) | TGFBR1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| WO-2012062844-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | TGFBR1 1875/4885FFAR1 629/4885HSP90AA1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.